◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

10-K Filing

SOTERA HEALTH CO CIK: 1822479 FY 2022
Filing Information
Form Type 10-K
Accession Number 0001822479-23-000015
Period End Date 20221231
Filing Date 20230228
Fiscal Year 2022
Fiscal Period FY
XBRL Instance shc-20221231_htm.xml
Filing Contents
Balance Sheet 113 line items
Line Item Tag Value Unit Period
Allowance for uncollectible accounts AllowanceForDoubtfulAccountsReceivableCurrent $1.87M USD Point-in-time
Allowance for uncollectible accounts AllowanceForDoubtfulAccountsReceivableCurrent $1.29M USD Point-in-time
Common stock, par value (in dollars per share) CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Common stock, par value (in dollars per share) CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Common stock, par value (in dollars per share) CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Common stock, shares authorized (in shares) CommonStockSharesAuthorized 1.20B shares Point-in-time
Common stock, shares authorized (in shares) CommonStockSharesAuthorized 1.20B shares Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $395.21M USD Point-in-time
Common stock, shares authorized (in shares) CommonStockSharesAuthorized 1.20B shares Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $106.92M USD Point-in-time
Restricted cash short-term RestrictedCashCurrent $1.08M USD Point-in-time
Restricted cash short-term RestrictedCashCurrent $7.00K USD Point-in-time
Common stock, shares issued (in shares) CommonStockSharesIssued 286.04M shares Point-in-time
Common stock, shares issued (in shares) CommonStockSharesIssued 286.04M shares Point-in-time
Accounts receivable, net of allowance for uncollectible accounts of $1,871 in 2022 and $1,287 in 2021, respectively AccountsReceivableNetCurrent $118.48M USD Point-in-time
Accounts receivable, net of allowance for uncollectible accounts of $1,871 in 2022 and $1,287 in 2021, respectively AccountsReceivableNetCurrent $108.18M USD Point-in-time
Preferred stock, par value (in dollars per share) PreferredStockParOrStatedValuePerShare $0.01 USD Point-in-time
Preferred stock, par value (in dollars per share) PreferredStockParOrStatedValuePerShare $0.01 USD Point-in-time
Preferred stock, par value (in dollars per share) PreferredStockParOrStatedValuePerShare $0.01 USD Point-in-time
Preferred stock, shares authorized (in shares) PreferredStockSharesAuthorized 120.00M shares Point-in-time
Inventories, net InventoryNet $54.29M USD Point-in-time
Preferred stock, shares authorized (in shares) PreferredStockSharesAuthorized 120.00M shares Point-in-time
Inventories, net InventoryNet $37.15M USD Point-in-time
Preferred stock, shares authorized (in shares) PreferredStockSharesAuthorized 120.00M shares Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $71.92M USD Point-in-time
Preferred stock, shares issued (in shares) PreferredStockSharesIssued 0.00 shares Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $81.00M USD Point-in-time
Preferred stock, shares issued (in shares) PreferredStockSharesIssued 0.00 shares Point-in-time
Income taxes receivable IncomeTaxesReceivable $12.09M USD Point-in-time
Income taxes receivable IncomeTaxesReceivable $4.64M USD Point-in-time
Treasury stock (in shares) TreasuryStockShares 3.05M shares Point-in-time
Treasury stock (in shares) TreasuryStockShares 3.62M shares Point-in-time
Total current assets AssetsCurrent $645.01M USD Point-in-time
Total current assets AssetsCurrent $345.96M USD Point-in-time
Property, plant, and equipment, net PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization $650.80M USD Point-in-time
Property, plant, and equipment, net PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization $774.53M USD Point-in-time
Operating lease assets OperatingLeaseRightOfUseAsset $26.48M USD Point-in-time
Operating lease assets OperatingLeaseRightOfUseAsset $39.95M USD Point-in-time
Deferred income taxes DeferredIncomeTaxAssetsNet $4.10M USD Point-in-time
Deferred income taxes DeferredIncomeTaxAssetsNet $5.88M USD Point-in-time
Investment in unconsolidated affiliate EquityMethodInvestments - USD Point-in-time
Investment in unconsolidated affiliate EquityMethodInvestments $9.40M USD Point-in-time
Post-retirement assets DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent $5.48M USD Point-in-time
Post-retirement assets DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent $35.57M USD Point-in-time
Other assets OtherAssetsNoncurrent $38.98M USD Point-in-time
Other assets OtherAssetsNoncurrent $12.87M USD Point-in-time
Other intangible assets, net IntangibleAssetsNetExcludingGoodwill $598.84M USD Point-in-time
Other intangible assets, net IntangibleAssetsNetExcludingGoodwill $491.26M USD Point-in-time
Goodwill Goodwill $1.12B USD Point-in-time
Goodwill Goodwill $1.10B USD Point-in-time
Goodwill Goodwill $1.12B USD Point-in-time
Total assets Assets $2.79B USD Point-in-time
Total assets Assets $3.12B USD Point-in-time
Accounts payable AccountsPayableCurrent $72.87M USD Point-in-time
Accounts payable AccountsPayableCurrent $74.14M USD Point-in-time
Accrued liabilities AccruedLiabilitiesCurrent $61.86M USD Point-in-time
Accrued liabilities AccruedLiabilitiesCurrent $490.13M USD Point-in-time
Deferred revenue ContractWithCustomerLiabilityCurrent $8.67M USD Point-in-time
Deferred revenue ContractWithCustomerLiabilityCurrent $12.14M USD Point-in-time
Current portion of long-term debt LongTermDebtCurrent $197.12M USD Point-in-time
Current portion of long-term debt LongTermDebtCurrent - USD Point-in-time
Current portion of finance lease obligations FinanceLeaseLiabilityCurrent $1.72M USD Point-in-time
Current portion of finance lease obligations FinanceLeaseLiabilityCurrent $1.16M USD Point-in-time
Current portion of operating lease obligations OperatingLeaseLiabilityCurrent $9.29M USD Point-in-time
Current portion of operating lease obligations OperatingLeaseLiabilityCurrent $7.55M USD Point-in-time
Current portion of asset retirement obligations AssetRetirementObligationCurrent $619.00K USD Point-in-time
Current portion of asset retirement obligations AssetRetirementObligationCurrent $2.90M USD Point-in-time
Income taxes payable AccruedIncomeTaxesCurrent $5.87M USD Point-in-time
Income taxes payable AccruedIncomeTaxesCurrent $6.70M USD Point-in-time
Total current liabilities LiabilitiesCurrent $791.57M USD Point-in-time
Total current liabilities LiabilitiesCurrent $161.16M USD Point-in-time
Long-term debt, less current portion LongTermDebtNoncurrent $1.74B USD Point-in-time
Long-term debt, less current portion LongTermDebtNoncurrent $1.75B USD Point-in-time
Finance lease obligations, less current portion FinanceLeaseLiabilityNoncurrent $56.95M USD Point-in-time
Finance lease obligations, less current portion FinanceLeaseLiabilityNoncurrent $40.88M USD Point-in-time
Operating lease obligations, less current portion OperatingLeaseLiabilityNoncurrent $33.02M USD Point-in-time
Operating lease obligations, less current portion OperatingLeaseLiabilityNoncurrent $21.58M USD Point-in-time
Noncurrent asset retirement obligations AssetRetirementObligationsNoncurrent $41.83M USD Point-in-time
Noncurrent asset retirement obligations AssetRetirementObligationsNoncurrent $42.59M USD Point-in-time
Deferred lease income DeferredRentCreditNoncurrent $20.75M USD Point-in-time
Deferred lease income DeferredRentCreditNoncurrent $18.90M USD Point-in-time
Post-retirement obligations PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent $11.46M USD Point-in-time
Post-retirement obligations PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent $7.91M USD Point-in-time
Noncurrent liabilities OtherLiabilitiesNoncurrent $16.27M USD Point-in-time
Noncurrent liabilities OtherLiabilitiesNoncurrent $12.83M USD Point-in-time
Deferred income taxes DeferredIncomeTaxLiabilitiesNet $134.50M USD Point-in-time
Deferred income taxes DeferredIncomeTaxLiabilitiesNet $68.02M USD Point-in-time
Total liabilities Liabilities $2.20B USD Point-in-time
Total liabilities Liabilities $2.77B USD Point-in-time
See Commitments and contingencies note CommitmentsAndContingencies - USD Point-in-time
See Commitments and contingencies note CommitmentsAndContingencies - USD Point-in-time
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 and 286,037 shares issued at December 31, 2022 and 2021, respectively CommonStockValue $2.86M USD Point-in-time
Common stock, with $0.01 par value, 1,200,000 shares authorized; 286,037 and 286,037 shares issued at December 31, 2022 and 2021, respectively CommonStockValue $2.86M USD Point-in-time
Preferred stock, with $0.01 par value, 120,000 shares authorized; no shares issued at December 31, 2022 and 2021 PreferredStockValue - USD Point-in-time
Preferred stock, with $0.01 par value, 120,000 shares authorized; no shares issued at December 31, 2022 and 2021 PreferredStockValue - USD Point-in-time
Treasury stock, at cost (3,616 and 3,052 shares at December 31, 2022 and 2021, respectively) TreasuryStockValue $29.77M USD Point-in-time
Treasury stock, at cost (3,616 and 3,052 shares at December 31, 2022 and 2021, respectively) TreasuryStockValue $33.55M USD Point-in-time
Additional paid-in capital AdditionalPaidInCapital $1.17B USD Point-in-time
Additional paid-in capital AdditionalPaidInCapital $1.19B USD Point-in-time
Retained deficit RetainedEarningsAccumulatedDeficit $-472.25M USD Point-in-time
Retained deficit RetainedEarningsAccumulatedDeficit $-705.82M USD Point-in-time
Accumulated other comprehensive loss AccumulatedOtherComprehensiveIncomeLossNetOfTax $-106.65M USD Point-in-time
Accumulated other comprehensive loss AccumulatedOtherComprehensiveIncomeLossNetOfTax $-83.57M USD Point-in-time
Total equity attributable to Sotera Health Company StockholdersEquity $350.24M USD Point-in-time
Total equity attributable to Sotera Health Company StockholdersEquity $586.10M USD Point-in-time
Noncontrolling interests MinorityInterest - USD Point-in-time
Noncontrolling interests MinorityInterest - USD Point-in-time
Total equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $350.24M USD Point-in-time
Total equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $-641.13M USD Point-in-time
Total equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $454.57M USD Point-in-time
Total equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $586.10M USD Point-in-time
Total liabilities and equity LiabilitiesAndStockholdersEquity $3.12B USD Point-in-time
Total liabilities and equity LiabilitiesAndStockholdersEquity $2.79B USD Point-in-time
Income Statement 90 line items
Line Item Tag Value Unit Period
Pension and post-retirement benefits, tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax $5.74M USD Annual
Pension and post-retirement benefits, tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax $-8.92M USD Annual
Pension and post-retirement benefits, tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax $-7.02M USD Annual
Interest rate swaps, tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax $142.00K USD Annual
Interest rate swaps, tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax $-63.00K USD Annual
Interest rate swaps, tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax $7.39M USD Annual
Total net revenues RevenueFromContractWithCustomerExcludingAssessedTax $1.00B USD Annual
Total net revenues RevenueFromContractWithCustomerExcludingAssessedTax $818.16M USD Annual
Total net revenues RevenueFromContractWithCustomerExcludingAssessedTax $931.48M USD Annual
Total cost of revenues CostOfRevenue $374.59M USD Annual
Total cost of revenues CostOfRevenue $446.68M USD Annual
Total cost of revenues CostOfRevenue $412.81M USD Annual
Gross profit GrossProfit $443.57M USD Annual
Gross profit GrossProfit $557.00M USD Annual
Gross profit GrossProfit $518.67M USD Annual
Selling, general and administrative expenses SellingGeneralAndAdministrativeExpense $245.71M USD Annual
Selling, general and administrative expenses SellingGeneralAndAdministrativeExpense $198.16M USD Annual
Selling, general and administrative expenses SellingGeneralAndAdministrativeExpense $178.53M USD Annual
Amortization of intangible assets AmortizationOfIntangibleAssetsNonproduction $63.78M USD Annual
Amortization of intangible assets AmortizationOfIntangibleAssetsNonproduction $62.94M USD Annual
Amortization of intangible assets AmortizationOfIntangibleAssetsNonproduction $59.03M USD Annual
Total operating expenses OperatingExpenses $261.94M USD Annual
Total operating expenses OperatingExpenses $308.65M USD Annual
Total operating expenses OperatingExpenses $237.55M USD Annual
Operating income OperatingIncomeLoss $256.73M USD Annual
Operating income OperatingIncomeLoss $206.02M USD Annual
Operating income OperatingIncomeLoss $248.35M USD Annual
Interest expense, net InterestIncomeExpenseNonoperatingNet $-215.26M USD Annual
Interest expense, net InterestIncomeExpenseNonoperatingNet $-80.14M USD Annual
Interest expense, net InterestIncomeExpenseNonoperatingNet $-74.19M USD Annual
Illinois EO litigation settlement GainLossRelatedToLitigationSettlement - USD Annual
Illinois EO litigation settlement GainLossRelatedToLitigationSettlement - USD Annual
Illinois EO litigation settlement GainLossRelatedToLitigationSettlement $-408.00M USD Annual
Impairment of investment in unconsolidated affiliate EquityMethodInvestmentOtherThanTemporaryImpairment - USD Annual
Impairment of investment in unconsolidated affiliate EquityMethodInvestmentOtherThanTemporaryImpairment $9.61M USD Annual
Impairment of investment in unconsolidated affiliate EquityMethodInvestmentOtherThanTemporaryImpairment - USD Annual
Loss on extinguishment of debt GainsLossesOnExtinguishmentOfDebt $-44.26M USD Annual
Loss on extinguishment of debt GainsLossesOnExtinguishmentOfDebt - USD Annual
Loss on extinguishment of debt GainsLossesOnExtinguishmentOfDebt $-20.68M USD Annual
Foreign exchange loss (gain) ForeignCurrencyTransactionGainLossBeforeTax $-1.34M USD Annual
Foreign exchange loss (gain) ForeignCurrencyTransactionGainLossBeforeTax $5.23M USD Annual
Foreign exchange loss (gain) ForeignCurrencyTransactionGainLossBeforeTax $-145.00K USD Annual
Other income, net OtherNonoperatingIncomeExpense $6.44M USD Annual
Other income, net OtherNonoperatingIncomeExpense $15.20M USD Annual
Other income, net OtherNonoperatingIncomeExpense $9.41M USD Annual
Income (loss) before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $175.72M USD Annual
Income (loss) before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-243.11M USD Annual
Income (loss) before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $-38.86M USD Annual
Provision (benefit) for income taxes IncomeTaxExpenseBenefit $58.59M USD Annual
Provision (benefit) for income taxes IncomeTaxExpenseBenefit $-1.37M USD Annual
Provision (benefit) for income taxes IncomeTaxExpenseBenefit $-9.54M USD Annual
Net income (loss) ProfitLoss $117.12M USD Annual
Net income (loss) ProfitLoss $-37.49M USD Annual
Net income (loss) ProfitLoss $-233.57M USD Annual
Less: Net income attributable to noncontrolling interests NetIncomeLossAttributableToNoncontrollingInterest - USD Annual
Less: Net income attributable to noncontrolling interests NetIncomeLossAttributableToNoncontrollingInterest $239.00K USD Annual
Less: Net income attributable to noncontrolling interests NetIncomeLossAttributableToNoncontrollingInterest $1.13M USD Annual
Net income (loss) attributable to Sotera Health Company NetIncomeLoss $116.88M USD Annual
Net income (loss) attributable to Sotera Health Company NetIncomeLoss $-38.62M USD Annual
Net income (loss) attributable to Sotera Health Company NetIncomeLoss $-233.57M USD Annual
Pension and post-retirement benefits (net of taxes of $7,022, $8,924 and $(5,737), respectively) OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $-26.56M USD Annual
Pension and post-retirement benefits (net of taxes of $7,022, $8,924 and $(5,737), respectively) OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $17.03M USD Annual
Pension and post-retirement benefits (net of taxes of $7,022, $8,924 and $(5,737), respectively) OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $-20.79M USD Annual
Interest rate derivatives (net of taxes of $7,387, $142 and $(63), respectively) OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax $404.00K USD Annual
Interest rate derivatives (net of taxes of $7,387, $142 and $(63), respectively) OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax $-179.00K USD Annual
Interest rate derivatives (net of taxes of $7,387, $142 and $(63), respectively) OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax $20.94M USD Annual
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $17.46M USD Annual
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-16.39M USD Annual
Foreign currency translation OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax $-64.82M USD Annual
Comprehensive income (loss) ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-256.66M USD Annual
Comprehensive income (loss) ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $127.69M USD Annual
Comprehensive income (loss) ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest $-37.24M USD Annual
Less: comprehensive income attributable to noncontrolling interests ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest - USD Annual
Less: comprehensive income attributable to noncontrolling interests ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest $534.00K USD Annual
Less: comprehensive income attributable to noncontrolling interests ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest $830.00K USD Annual
Comprehensive income (loss) attributable to Sotera Health Company ComprehensiveIncomeNetOfTax $-256.66M USD Annual
Comprehensive income (loss) attributable to Sotera Health Company ComprehensiveIncomeNetOfTax $-38.07M USD Annual
Comprehensive income (loss) attributable to Sotera Health Company ComprehensiveIncomeNetOfTax $127.16M USD Annual
Basic (in dollars per share) EarningsPerShareBasic $-0.83 USD Annual
Basic (in dollars per share) EarningsPerShareBasic $-0.16 USD Annual
Basic (in dollars per share) EarningsPerShareBasic $0.41 USD Annual
Diluted (in dollars per share) EarningsPerShareDiluted $0.41 USD Annual
Diluted (in dollars per share) EarningsPerShareDiluted $-0.16 USD Annual
Diluted (in dollars per share) EarningsPerShareDiluted $-0.83 USD Annual
Basic (in shares) WeightedAverageNumberOfSharesOutstandingBasic 237.70M shares Annual
Basic (in shares) WeightedAverageNumberOfSharesOutstandingBasic 280.10M shares Annual
Basic (in shares) WeightedAverageNumberOfSharesOutstandingBasic 279.23M shares Annual
Diluted (in shares) WeightedAverageNumberOfDilutedSharesOutstanding 237.70M shares Annual
Diluted (in shares) WeightedAverageNumberOfDilutedSharesOutstanding 279.38M shares Annual
Diluted (in shares) WeightedAverageNumberOfDilutedSharesOutstanding 280.10M shares Annual
Cash Flow Statement 137 line items
Line Item Tag Value Unit Period
Net income (loss) ProfitLoss $117.12M USD Annual
Net income (loss) ProfitLoss $-37.49M USD Annual
Net income (loss) ProfitLoss $-233.57M USD Annual
Depreciation Depreciation $64.16M USD Annual
Depreciation Depreciation $63.31M USD Annual
Depreciation Depreciation $64.00M USD Annual
Amortization of intangible assets AmortizationOfIntangibleAssets $81.55M USD Annual
Amortization of intangible assets AmortizationOfIntangibleAssets $86.74M USD Annual
Amortization of intangible assets AmortizationOfIntangibleAssets $80.25M USD Annual
Impairment of investment in unconsolidated affiliate EquityMethodInvestmentOtherThanTemporaryImpairment - USD Annual
Impairment of investment in unconsolidated affiliate EquityMethodInvestmentOtherThanTemporaryImpairment $9.61M USD Annual
Impairment of investment in unconsolidated affiliate EquityMethodInvestmentOtherThanTemporaryImpairment - USD Annual
Loss on extinguishment of debt GainsLossesOnExtinguishmentOfDebt $-44.26M USD Annual
Loss on extinguishment of debt GainsLossesOnExtinguishmentOfDebt - USD Annual
Loss on extinguishment of debt GainsLossesOnExtinguishmentOfDebt $-20.68M USD Annual
Deferred income taxes DeferredIncomeTaxExpenseBenefit $-3.72M USD Annual
Deferred income taxes DeferredIncomeTaxExpenseBenefit $-73.96M USD Annual
Deferred income taxes DeferredIncomeTaxExpenseBenefit $-23.36M USD Annual
Share-based compensation expense ShareBasedCompensation $13.87M USD Annual
Share-based compensation expense ShareBasedCompensation $21.21M USD Annual
Share-based compensation expense ShareBasedCompensation $10.99M USD Annual
Accretion expense AssetRetirementObligationAccretionExpense $2.25M USD Annual
Accretion expense AssetRetirementObligationAccretionExpense $2.00M USD Annual
Accretion expense AssetRetirementObligationAccretionExpense $2.19M USD Annual
Unrealized foreign exchange (gain) loss ForeignCurrencyTransactionGainLossUnrealized $10.60M USD Annual
Unrealized foreign exchange (gain) loss ForeignCurrencyTransactionGainLossUnrealized $-788.00K USD Annual
Unrealized foreign exchange (gain) loss ForeignCurrencyTransactionGainLossUnrealized $3.98M USD Annual
Unrealized loss (gain) on derivatives not designated as hedging instruments UnrealizedGainLossOnDerivatives $-2.98M USD Annual
Unrealized loss (gain) on derivatives not designated as hedging instruments UnrealizedGainLossOnDerivatives $1.20M USD Annual
Unrealized loss (gain) on derivatives not designated as hedging instruments UnrealizedGainLossOnDerivatives $3.07M USD Annual
Amortization of debt issuance costs AmortizationOfFinancingCosts $6.16M USD Annual
Amortization of debt issuance costs AmortizationOfFinancingCosts $11.62M USD Annual
Amortization of debt issuance costs AmortizationOfFinancingCosts $5.68M USD Annual
Other OtherNoncashIncomeExpense $6.99M USD Annual
Other OtherNoncashIncomeExpense $5.54M USD Annual
Other OtherNoncashIncomeExpense $12.73M USD Annual
Accounts receivable IncreaseDecreaseInAccountsReceivable $15.51M USD Annual
Accounts receivable IncreaseDecreaseInAccountsReceivable $12.55M USD Annual
Accounts receivable IncreaseDecreaseInAccountsReceivable $-1.94M USD Annual
Inventories IncreaseDecreaseInInventories $-14.44M USD Annual
Inventories IncreaseDecreaseInInventories $-3.78M USD Annual
Inventories IncreaseDecreaseInInventories $20.25M USD Annual
Other current assets IncreaseDecreaseInOtherCurrentAssets $7.77M USD Annual
Other current assets IncreaseDecreaseInOtherCurrentAssets $5.82M USD Annual
Other current assets IncreaseDecreaseInOtherCurrentAssets $3.55M USD Annual
Accounts payable IncreaseDecreaseInAccountsPayable $19.76M USD Annual
Accounts payable IncreaseDecreaseInAccountsPayable $1.11M USD Annual
Accounts payable IncreaseDecreaseInAccountsPayable $-6.02M USD Annual
Accrued liabilities IncreaseDecreaseInAccruedLiabilities $3.25M USD Annual
Accrued liabilities IncreaseDecreaseInAccruedLiabilities $20.59M USD Annual
Accrued liabilities IncreaseDecreaseInAccruedLiabilities $1.60M USD Annual
Illinois EO litigation settlement GainLossRelatedToLitigationSettlement - USD Annual
Illinois EO litigation settlement GainLossRelatedToLitigationSettlement - USD Annual
Illinois EO litigation settlement GainLossRelatedToLitigationSettlement $-408.00M USD Annual
Income taxes payable / receivable IncreaseDecreaseInAccruedIncomeTaxesPayable $10.10M USD Annual
Income taxes payable / receivable IncreaseDecreaseInAccruedIncomeTaxesPayable $-8.14M USD Annual
Income taxes payable / receivable IncreaseDecreaseInAccruedIncomeTaxesPayable $-12.33M USD Annual
Other liabilities IncreaseDecreaseInOtherNoncurrentLiabilities $-657.00K USD Annual
Other liabilities IncreaseDecreaseInOtherNoncurrentLiabilities $383.00K USD Annual
Other liabilities IncreaseDecreaseInOtherNoncurrentLiabilities $-369.00K USD Annual
Other long-term assets IncreaseDecreaseInOtherNoncurrentAssets $-1.82M USD Annual
Other long-term assets IncreaseDecreaseInOtherNoncurrentAssets $4.59M USD Annual
Other long-term assets IncreaseDecreaseInOtherNoncurrentAssets $4.38M USD Annual
Net cash provided by operating activities NetCashProvidedByUsedInOperatingActivities $281.55M USD Annual
Net cash provided by operating activities NetCashProvidedByUsedInOperatingActivities $120.58M USD Annual
Net cash provided by operating activities NetCashProvidedByUsedInOperatingActivities $277.96M USD Annual
Purchases of property, plant and equipment PaymentsToAcquirePropertyPlantAndEquipment $53.51M USD Annual
Purchases of property, plant and equipment PaymentsToAcquirePropertyPlantAndEquipment $102.16M USD Annual
Purchases of property, plant and equipment PaymentsToAcquirePropertyPlantAndEquipment $182.38M USD Annual
Purchase of Iotron Industries Canada, Inc., net of cash acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired - USD Annual
Purchase of Iotron Industries Canada, Inc., net of cash acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired $105.19M USD Annual
Purchase of Iotron Industries Canada, Inc., net of cash acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired - USD Annual
Purchase of BioScience Laboratories, LLC, net of cash acquired PaymentsToAcquireBusinessesNetOfCashAcquired $13.53M USD Annual
Purchase of BioScience Laboratories, LLC, net of cash acquired PaymentsToAcquireBusinessesNetOfCashAcquired - USD Annual
Purchase of BioScience Laboratories, LLC, net of cash acquired PaymentsToAcquireBusinessesNetOfCashAcquired - USD Annual
Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc. PaymentsToAcquireAdditionalInterestInSubsidiaries - USD Annual
Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc. PaymentsToAcquireAdditionalInterestInSubsidiaries - USD Annual
Purchase of mandatorily redeemable noncontrolling interest in Nelson Laboratories Fairfield, Inc. PaymentsToAcquireAdditionalInterestInSubsidiaries $12.43M USD Annual
Purchase of Regulatory Compliance Associates Inc., net of cash acquired PaymentsToAcquireBusinessThreeNetOfCashAcquired $-450.00K USD Annual
Purchase of Regulatory Compliance Associates Inc., net of cash acquired PaymentsToAcquireBusinessThreeNetOfCashAcquired - USD Annual
Purchase of Regulatory Compliance Associates Inc., net of cash acquired PaymentsToAcquireBusinessThreeNetOfCashAcquired $31.02M USD Annual
Other investing activities PaymentsForProceedsFromOtherInvestingActivities - USD Annual
Other investing activities PaymentsForProceedsFromOtherInvestingActivities $701.00K USD Annual
Other investing activities PaymentsForProceedsFromOtherInvestingActivities $-32.00K USD Annual
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities $-181.90M USD Annual
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities $-159.83M USD Annual
Net cash used in investing activities NetCashProvidedByUsedInInvestingActivities $-158.69M USD Annual
Proceeds from revolving credit facility and long-term borrowings ProceedsFromIssuanceOfLongTermDebt $200.00M USD Annual
Proceeds from revolving credit facility and long-term borrowings ProceedsFromIssuanceOfLongTermDebt $150.00M USD Annual
Proceeds from revolving credit facility and long-term borrowings ProceedsFromIssuanceOfLongTermDebt - USD Annual
Proceeds from issuance of common stock, net of underwriting discounts and issuance costs ProceedsFromIssuanceOfCommonStock - USD Annual
Proceeds from issuance of common stock, net of underwriting discounts and issuance costs ProceedsFromIssuanceOfCommonStock $1.16B USD Annual
Proceeds from issuance of common stock, net of underwriting discounts and issuance costs ProceedsFromIssuanceOfCommonStock - USD Annual
Repurchase of common shares PaymentsForRepurchaseOfCommonStock $34.00M USD Annual
Repurchase of common shares PaymentsForRepurchaseOfCommonStock - USD Annual
Repurchase of common shares PaymentsForRepurchaseOfCommonStock - USD Annual
Purchase of noncontrolling interests in China subsidiaries PaymentsToMinorityShareholders - USD Annual
Purchase of noncontrolling interests in China subsidiaries PaymentsToMinorityShareholders $8.42M USD Annual
Purchase of noncontrolling interests in China subsidiaries PaymentsToMinorityShareholders - USD Annual
Payments of debt issuance costs and prepayment premium PaymentsOfDebtIssuanceCosts $31.00K USD Annual
Payments of debt issuance costs and prepayment premium PaymentsOfDebtIssuanceCosts $19.75M USD Annual
Payments of debt issuance costs and prepayment premium PaymentsOfDebtIssuanceCosts $6.79M USD Annual
Payments on revolving credit facility and long-term borrowings RepaymentsOfLongTermDebt - USD Annual
Payments on revolving credit facility and long-term borrowings RepaymentsOfLongTermDebt $1.18B USD Annual
Payments on revolving credit facility and long-term borrowings RepaymentsOfLongTermDebt $100.00M USD Annual
Shares withheld for employee taxes on equity awards PaymentsRelatedToTaxWithholdingForShareBasedCompensation $393.00K USD Annual
Shares withheld for employee taxes on equity awards PaymentsRelatedToTaxWithholdingForShareBasedCompensation $1.43M USD Annual
Shares withheld for employee taxes on equity awards PaymentsRelatedToTaxWithholdingForShareBasedCompensation - USD Annual
Other financing activities ProceedsFromPaymentsForOtherFinancingActivities $-1.81M USD Annual
Other financing activities ProceedsFromPaymentsForOtherFinancingActivities $-642.00K USD Annual
Other financing activities ProceedsFromPaymentsForOtherFinancingActivities $-1.46M USD Annual
Net cash provided by (used in) financing activities NetCashProvidedByUsedInFinancingActivities $73.43M USD Annual
Net cash provided by (used in) financing activities NetCashProvidedByUsedInFinancingActivities $-117.29M USD Annual
Net cash provided by (used in) financing activities NetCashProvidedByUsedInFinancingActivities $197.76M USD Annual
Effect of exchange rate changes on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $44.00K USD Annual
Effect of exchange rate changes on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $-4.46M USD Annual
Effect of exchange rate changes on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $4.11M USD Annual
Net increase (decrease) in cash and cash equivalents, including restricted cash CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $39.43M USD Annual
Net increase (decrease) in cash and cash equivalents, including restricted cash CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $289.37M USD Annual
Net increase (decrease) in cash and cash equivalents, including restricted cash CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $4.47M USD Annual
Cash and cash equivalents, including restricted cash, at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $63.02M USD Point-in-time
Cash and cash equivalents, including restricted cash, at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $106.92M USD Point-in-time
Cash and cash equivalents, including restricted cash, at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $102.45M USD Point-in-time
Cash and cash equivalents, including restricted cash, at beginning of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $396.29M USD Point-in-time
Cash and cash equivalents, including restricted cash, at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $63.02M USD Point-in-time
Cash and cash equivalents, including restricted cash, at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $106.92M USD Point-in-time
Cash and cash equivalents, including restricted cash, at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $102.45M USD Point-in-time
Cash and cash equivalents, including restricted cash, at end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents $396.29M USD Point-in-time
Cash paid during the period for interest InterestPaidNet $58.77M USD Annual
Cash paid during the period for interest InterestPaidNet $211.28M USD Annual
Cash paid during the period for interest InterestPaidNet $75.85M USD Annual
Cash paid during the period for income taxes, net of tax refunds received IncomeTaxesPaidNet $23.99M USD Annual
Cash paid during the period for income taxes, net of tax refunds received IncomeTaxesPaidNet $75.50M USD Annual
Cash paid during the period for income taxes, net of tax refunds received IncomeTaxesPaidNet $52.01M USD Annual
Purchases of property, plant and equipment included in accounts payable CapitalExpendituresIncurredButNotYetPaid $14.52M USD Annual
Purchases of property, plant and equipment included in accounts payable CapitalExpendituresIncurredButNotYetPaid $14.29M USD Annual
Purchases of property, plant and equipment included in accounts payable CapitalExpendituresIncurredButNotYetPaid $16.41M USD Annual
Stockholders Equity 28 line items
Line Item Tag Value Unit Period
Beginning Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $350.24M USD Point-in-time
Beginning Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $-641.13M USD Point-in-time
Beginning Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $454.57M USD Point-in-time
Beginning Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $586.10M USD Point-in-time
Acquisition of noncontrolling interests MinorityInterestDecreaseFromRedemptions $8.58M USD Annual
Acquisition of noncontrolling interests MinorityInterestDecreaseFromRedemptions $2.80M USD 1 Quarter
Issuance of shares StockIssuedDuringPeriodValueNewIssues $1.08M USD Annual
Issuance of shares StockIssuedDuringPeriodValueNewIssues $1.16B USD Annual
Repurchase of shares StockRepurchasedDuringPeriodValue $34.00M USD Annual
Share-based compensation plans StockIssuedDuringPeriodValueShareBasedCompensation $10.99M USD Annual
Share-based compensation plans StockIssuedDuringPeriodValueShareBasedCompensation $20.80M USD Annual
Share-based compensation plans StockIssuedDuringPeriodValueShareBasedCompensation $11.33M USD Annual
Pension and post-retirement plan adjustments, net of tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $-26.56M USD Annual
Pension and post-retirement plan adjustments, net of tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $17.03M USD Annual
Pension and post-retirement plan adjustments, net of tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $-20.79M USD Annual
Foreign currency translation OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent $-16.39M USD Annual
Foreign currency translation OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent $-64.82M USD Annual
Foreign currency translation OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent $17.46M USD Annual
Interest rate derivatives, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax $404.00K USD Annual
Interest rate derivatives, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax $-179.00K USD Annual
Interest rate derivatives, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax $20.94M USD Annual
Net (loss) income ProfitLoss $117.12M USD Annual
Net (loss) income ProfitLoss $-37.49M USD Annual
Net (loss) income ProfitLoss $-233.57M USD Annual
Ending Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $350.24M USD Point-in-time
Ending Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $-641.13M USD Point-in-time
Ending Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $454.57M USD Point-in-time
Ending Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $586.10M USD Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...